Whole-genome DASL-based gene expression profiling based on 18.6 k genes identified 349 significantly deregulated genes with up-regulation of e.g. PTPRH, BIRC3, SHH and TNFRSF6B in Lynch syndrome tumors. This evidence concerns the gene BIRC3 and Lynch syndrome.